Supraventricular Tachycardia
📧 Sign up to get email alerts when something new happens for Supraventricular Tachycardia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-10-05FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for amiodarone hydrochloride submitted by Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Comparative Study Between Cryoablation and Radiofrequency Ablation in the Treatment of Supraventricular Tachycardia [Phase 4]
This trial update compares cryoablation and radiofrequency ablation for treating supraventricular tachycardia, including AV nodal reentrant …
-
FDA approval · 2015-07-02FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for amiodarone hydrochloride by Advagen Pharma Limited. This action confirms regulatory clearance fo…
-
FDA label_change · 2015-03-23FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental labeling application for Cardizem LA (diltiazem hydrochloride extended-release tablets) from Bausch Health US LL…
-
FDA approval · 2015-01-26FDA Approved: BREVIBLOC — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Brevibloc (esmolol hydrochloride) submitted by Baxter Healthcare Corporation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Sevoflurane and Isoflurane for RF or Cryo Ablation in Children.
The clinical trial evaluating sevoflurane and isoflurane anesthesia during RF or cryoablation in children with supraventricular tachycardia …
-
CLINICAL_TRIALS research · 2014-06-26Clinical Trial Update: Sternal ECG Patch Comparison Trial
A clinical trial update concerning Bardy Diagnostics' sternal ECG patch comparison trial, focusing on patients with syncope and related cond…
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate Shock [Phase 4]
Phase 4 clinical trial evaluating a dual-chamber implantable cardioverter-defibrillator with specialized programming features aimed at reduc…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: TOCCATA - Touch+™ for Catheter Ablation [NA]
Abbott's TOCCATA Touch+ catheter ablation trial completed and posted results; the study focused on atrial fibrillation and supraventricular …
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: Multicenter Study of Antiarrhythmic Medications for Treatment of Infants With Supraventricular Tachycardia [Phase 3]
Phase 3 multicenter trial assessing antiarrhythmic medications for infants with supraventricular tachycardia has completed. Results were pos…
-
FDA approval · 2013-05-31FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for amiodarone hydrochloride submitted by Chartwell RX, LLC. This marks an approval of a supplement …
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Radiation Exposure Reduction in Supraventricular Tachycardia Ablation [Phase 4]
Phase 4 clinical trial update on radiation exposure reduction during ablation for supraventricular tachycardia; the study is completed.
-
FDA approval · 2012-11-26FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for verapamil hydrochloride from Actavis Pharma, Inc. for an already authorized product.
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT) [NA]
Completed RESPECT trial evaluating septal pacing to reduce arrhythmic episodes in patients with atrial fibrillation and related tachycardias…
-
CLINICAL_TRIALS trial_result · 2012-01-10Clinical Trial Update: The Simple ECG Monitoring Trial (Comparison of a Novel Recording System With a Standard Holter Monitor)
This trial compared a novel ECG recording system with a standard Holter monitor to evaluate arrhythmia detection. The study, conducted in pa…
-
FDA approval · 2011-11-14FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)
FDA approved a supplemental application for Verapamil hydrochloride submitted by Teva Pharmaceuticals Inc. This action finalizes changes to …
-
FDA approval · 2011-11-02FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (EXELA PHARMA SCIENCES, LLC)
FDA approved a supplemental NDA for Verapamil Hydrochloride from Exela Pharma Sciences, LLC under NDA 018925.
-
FDA approval · 2011-10-28FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s supplemental application for CARTIA XT (diltiazem hydrochloride) under ANDA074752.
-
FDA approval · 2011-08-03FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved verapamil hydrochloride as an original application generic drug by Glenmark; the product is indicated for conditions treated by…
-
FDA approval · 2011-07-11FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for propafenone hydrochloride, enabling its generic marketing by Strides Pharma Science Limited as a…
-
FDA approval · 2011-01-27FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Diltiazem Hydrochloride from Teva Pharmaceuticals USA, Inc., updating the product's regulato…
-
FDA approval · 2011-01-20FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for diltiazem hydrochloride (Apotex Corp.), a generic calcium channel blocker. The approval covers t…
-
FDA approval · 2011-01-13FDA Approved: ADENOSINE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for adenosine from Mylan Institutional LLC.
-
FDA approval · 2010-11-22FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental NDA for Cardizem CD (diltiazem hydrochloride) submitted by Bausch Health US LLC.
-
FDA approval · 2010-10-18FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approves a supplemental application for Propafenone hydrochloride from Strides Pharma Science Limited to market its generic product.